Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acquired Immunodeficiency Syndrome × Nevirapine × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 10 Zidovudine 8 Vincristine 7 Bleomycin 7 Liposomes 5 Interferon alpha-2 5 tecogalan 3 Etoposide 3 sargramostim 2 pomalidomide 2 liposomal doxorubicin 2 interferon alfa-n1 2 Valganciclovir 2 Ritonavir 2 Paclitaxel 2 Nivolumab 2 Didanosine 2 vesnarinone 1 tocilizumab 1 tin etiopurpurin 1 abemaciclib 1 Zalcitabine 1 Tumor Necrosis Factor-alpha 1 Sorafenib 1 Semaxinib 1 Ro 24-7429 1 Nevirapine 1 NHS-IL12 immunocytokine 1 Muromonab-CD3 1 Mitoxantrone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00380770 2010-07-21

KAART

University of KwaZulu

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡